Skip to main content

Day: March 24, 2021

ProVen Growth and Income VCT plc: Publication of a supplementary prospectus

ProVen VCT plcProVen Growth and Income VCT plcPublication of Supplementary Prospectus24 March 2021 ProVen VCT plc and ProVen Growth and Income VCT plc (the “Companies”) published a prospectus on 3 December 2020 (comprising a securities note, a registration document and a summary (the “Prospectus”)) relating to the offer for subscription by the Companies to raise up to £40 million by way of an issue of new ordinary shares in the Companies, with each raising up to £20 million (together with an over-allotment facility for each company to raise up to a further £10 million). The Companies have announced that they do not intend to utilise the over-allotment facility and the offer for shares by the Companies under the Prospectus is closed to further applications. On 18 March 2021 each of the Companies published an unaudited net asset value per...

Continue reading

Afya Limited to Report Fourth Quarter 2020 and 2020 Unaudited Financial Results on April 8

NOVA LIMA, Brazil and MINAS GERAIS, Brazil, March 24, 2021 (GLOBE NEWSWIRE) — Afya Limited, or Afya (Nasdaq: AFYA), today announced that it will report fourth quarter 2020 and 2020 unaudited financial results for the period ended December 31, 2020, following the close of the market on Thursday, April 8th, 2021. The Company will host a corresponding conference call and webcast on April 9 at 10:00 AM EDT. More details about the call will be available in the week of the event. A live and archived webcast of the call will be available on the Investor Relations section of the Company’s website at https://ir.afya.com.br/. About Afya Limited (Nasdaq: AFYA) Afya is a leading medical education group in Brazil based on number of medical school seats, delivering an end-to-end physician-centric ecosystem that serves and empowers students and...

Continue reading

Dyadic et Medytox vont développer des vaccins contre les variants de la COVID-19

Expansion de la collaboration existante en matière de recherche sur les vaccins contre la COVID-19 qui a débuté en juillet 2020. Medytox et Dyadic vont développer conjointement des vaccins et/ou des rappels contre la COVID-19 à partir de la C1, qui immuniseront les personnes contre deux ou plusieurs des variants actuels et futurs de la COVID-19 (par exemple, les vaccins tétravalents ou quadrivalents contre la COVID-19) Licence exclusive pour la République de Corée et plusieurs pays d’Asie du Sud-est, en cas de succès Les protocoles de fabrication pour la production de vaccins à partir de la C1 ont été transférés et reproduits avec succès chez MedytoxJUPITER, Floride, 24 mars 2021 (GLOBE NEWSWIRE) — Dyadic International, Inc. (« Dyadic », « nous », « notre », « nos » ou la « Société ») (NASDAQ : DYAI), une société mondiale...

Continue reading

Dyadic und Medytox entwickeln Impfstoffe gegen COVID-19-Varianten

Ausweitung der seit Juli 2020 bestehenden Zusammenarbeit im Bereich der COVID-19-Impfstoffforschung Medytox und Dyadic entwickeln gemeinsam COVID-19-Impfstoffe und/oder Booster aus C1, die Menschen gegen zwei oder mehr der aktuellen und zukünftigen COVID-19-Varianten immunisieren (d. h. tetravalente oder quadrivalente COVID-19-Impfstoffe) Exklusive Lizenz für die Republik Korea und mehrere südostasiatische Länder im Falle des Erfolgs Herstellungsprotokolle zur Produktion von Impfstoffen aus C1 wurden erfolgreich übertragen und bei Medytox reproduziertJUPITER, Florida, March 24, 2021 (GLOBE NEWSWIRE) — Dyadic International, Inc. („Dyadic“, „wir“, „uns“, „unser“ oder das „Unternehmen“) (NASDAQ: DYAI), ein weltweit tätiges Biotechnologieunternehmen, das sich auf die weitere Verbesserung, Anwendung und Bereitstellung seiner unternehmenseigenen...

Continue reading

LPL Financial Welcomes Progressive Financial Concepts

CHARLOTTE, N.C., March 24, 2021 (GLOBE NEWSWIRE) — LPL Financial LLC (Nasdaq:LPLA) today announced that Progressive Financial Concepts has joined LPL Financial’s broker-dealer, corporate registered investment advisor (RIA) and custodial platforms, aligned with The Wealth Consulting Group (WCG), a large enterprise supporting LPL advisors. The Progressive team reported having served approximately $450 million in advisory, brokerage and retirement plan assets*. They join LPL from Sagepoint Financial, part of the Advisor Group network of broker-dealers. Based in Scottsdale, Ariz., the team of financial advisors includes Kory Budinger, Michael Apsell, Eric Black, Greg Morell, Stan Waldrop and Brian West. The advisors have worked together for more than 20 years, taking an integrated team approach to provide multigenerational wealth management...

Continue reading

180 Life Sciences Corp. CEO James Woody, MD, PhD Issues Letter to Stockholders

MENLO PARK, Calif., March 24, 2021 (GLOBE NEWSWIRE) — 180 Life Sciences Corp. (NASDAQ: ATNF, the “Company”), a clinical-stage biotechnology company with its lead indication in Phase 2b/3 clinical trial, focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today released the following letter to stockholders from its Chief Executive Officer, Dr. James Woody. Dear Fellow Stockholder, It has been a busy and productive few months here at 180 Life Sciences. As you may recall, I previously authored a letter to you mid-November 2020, on the heels of our going public through the closing of a merger with KBL Merger Corp IV (“KBL”), resulting in 180 Life Sciences becoming a stand-alone publicly-traded company and its common stock being listed on The NASDAQ Capital Market...

Continue reading

Primoris Services Corporation Secures Heavy Civil Project Valued over $35 million

DALLAS, March 24, 2021 (GLOBE NEWSWIRE) — Primoris Services Corporation (NASDAQ Global Select: PRIM) (“Primoris” or “Company”) today announced a new heavy civil project with a total value of over $35 million. The contract was secured by the Company’s Energy Segment.The project was awarded by the Texas Department of Transportation and is in Midland, Texas. The project is for the reconstruction of both the frontage roads and main lanes of Interstate 20. The project involves the removal and replacement of existing surfaces, paving of both concrete and asphalt, drainage, new bridge construction and safety items such as signage, guardrails, and barriers. Work will commence in the second quarter of 2021, with completion expected in the fourth quarter of 2023.ABOUT PRIMORISFounded in 1960, Primoris is one of the leading providers of...

Continue reading

Amesite Inc. (NASDAQ: AMST) Establishes New Paradigm in Surging E-Learning Space

NEW YORK, March 24, 2021 (GLOBE NEWSWIRE) — via InvestorWire — Amesite Inc. (NASDAQ: AMST) today announces its placement in an editorial published by NetworkNewsWire (“NNW”), one of 50+ trusted brands within the InvestorBrandNetwork (“IBN”), a multifaceted financial news and publishing company for private and public entities. To view the full publication, “The Move to e-Learning Is Heating Up,” please visit: https://nnw.fm/aQlsU To deliver e-learning that works, tech platforms must address and meet the widely disparate needs of individual schools and varied businesses. A one-size-fits-all approach is doomed to fail when trying to educate, especially in a virtual venue. There’s a critical need for tailored programs as well as wholesale improvement in the way content is created and delivered. Technology innovator...

Continue reading

Verde Bio Holdings, Inc. Closes Acquisition of Mineral and Royalty Interests

–Acquisition Includes Revenue Producing Assets in Haynesville Shale of Louisiana and Delaware Basin of Texas– FRISCO, TEXAS, March 24, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — Verde Bio Holdings, Inc. (OTC: VBHI) today announced that it has closed on the Haynesville Shale portion of a previously announced purchase as well as another property located in Reeves County, Texas, for a combined purchase price of $127,500. Verde is entitled to the cash flow on both properties from production attributable to the acquisition beginning on or after March 1, 2021. The two deals bring the total number of acquisitions to six for the Company to date. Scott Cox, Director and Chief Executive Officer of Verde Bio Holdings, said, “These two properties are great additions to our portfolio of high-quality, revenue producing...

Continue reading

One Step Vending Corp. Announces Strategic Sales Agreement with The Jet Collection

Harrison, New York, March 24, 2021 (GLOBE NEWSWIRE) — via NewMediaWire — One Step Vending, Corp. (OTC Markets: KOSK), a company specializing in emerging industries acquisitions with an emphasis in the self-serve vending market, is pleased to announce that it has entered into a Sales Agency Agreement with The Jet Collection, a private US entity specialized in the Consumer-packaged goods space. JET’s executives are influential Consumer Packaged Goods (CPG) professionals with a combined 50 plus years’ experience of successfully launching brands and growing sales. The Sales Agency Agreement includes the placement of vending machines in popular chains of grocery stores and other places starting with the area of Las Vegas. Jet Collection will work diligently to develop and grow the network of vending machines in targeted...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.